about
Oral tumors in children: Diagnosis and Management.New 6(17)-epoxylathyrane diterpene: aellinane from Euphorbia aellenii induces apoptosis via mitochondrial pathway in ovarian cancer cell line.Cdc6 expression is induced by HPV16 E6 and E7 oncogenes and represses E-cadherin expression.The effect of oxamflatin on the E-cadherin expression in gastric cancer cell line.Stroke in Women: Risk Factors and Clinical Biomarkers.NLRP3 inflammasome: Its regulation and involvement in atherosclerosis.MicroRNAs-Based Imaging Techniques in Cancer Diagnosis and Therapy.Therapeutic application of multipotent stem cells.Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis.Nanoparticles as new tools for inhibition of cancer angiogenesis.Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases.Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis.MicroRNA: A novel target of curcumin in cancer therapy.MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers.Mesenchymal stem cells: A new platform for targeting suicide genes in cancer.Anoikis resistance and oncoviruses.Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exosomes.MiR-21: A key player in glioblastoma pathogenesis.Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome.Molecular mechanisms of drug resistance in ovarian cancer.Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.
P2860
Q38644148-B0829A0A-0F52-4570-852E-6A17B89F1C5EQ38699019-89CEF509-19B6-4EA3-AFA9-F646DB78E916Q38731807-905A0027-3FC8-412D-8A31-8371E09F37AAQ38739161-6B500AEA-C04F-4A22-8871-9871F8856A93Q38789375-E0A3E6B4-9686-4146-820F-50F1301ED77CQ39202038-C8A6CE60-9848-407F-8ED5-36A35F40EF0DQ39215885-08D33133-70E9-4454-94F2-D9E3B2046C3EQ39285733-FDB62F3C-2A93-409D-AB07-A3080E745BAAQ39315148-3694E5F5-FBA6-4613-BADD-1737D93E2042Q39329359-CCCE98B6-5B03-4F2A-9D88-E7039591E769Q39329517-AB7AC1D5-5594-4BF7-AD11-F2B2177C0B16Q39368829-72AB0778-6807-4886-B89D-FB1615AE9006Q39375777-7003F140-7F57-4380-9542-B13467212426Q39402059-8F9FE31F-D4D7-422F-974E-605971ABD3F5Q39432344-6EA763A4-8AEB-408C-B339-5EBA3D68319EQ40072469-4BCE40E4-DBB0-45D6-B136-AB1D849211A8Q41928848-E9789B9A-B697-487B-B8B3-0027DFC56D1BQ48095332-FAF40BE2-AF7F-436C-8FA9-86500B2B735DQ48157286-D08C1BD1-4D7D-4231-8190-107BF4A6FBCDQ48274587-1DCF80ED-7F9D-4031-AA64-2ACAEC12506CQ52941950-5C787C58-B9B7-4EE0-919D-9196D98E9142
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
SiRNA and epigenetic aberrations in ovarian cancer
@ast
SiRNA and epigenetic aberrations in ovarian cancer
@en
SiRNA and epigenetic aberrations in ovarian cancer
@nl
type
label
SiRNA and epigenetic aberrations in ovarian cancer
@ast
SiRNA and epigenetic aberrations in ovarian cancer
@en
SiRNA and epigenetic aberrations in ovarian cancer
@nl
prefLabel
SiRNA and epigenetic aberrations in ovarian cancer
@ast
SiRNA and epigenetic aberrations in ovarian cancer
@en
SiRNA and epigenetic aberrations in ovarian cancer
@nl
P2093
P356
P1476
SiRNA and epigenetic aberrations in ovarian cancer
@en
P2093
Foad Yazdi
Hamed Mirzaei
Hamid Reza Mirzaei
Rasoul Salehi
P304
P356
10.4103/0973-1482.153661
P407
P577
2016-01-01T00:00:00Z